International Cannabis Weekly: 344

CURALEAF EYES SECONDARY LISTING IN EUROPE

Curaleaf, the largest grower and distributor of cannabis in the world, is reportedly exploring a secondary listing in Germany.

READ MORE  »

CANCELLED LICENCES AND ‘UNCOLLECTABLE’ EXCISE TAX IN CANADA SOAR

READ MORE »

GREEK HEALTH MINISTER TO SPEAK IN LONDON AT CANNABIS EUROPA THIS JUNE

READ MORE »

• Artemis Growth Partners and Tenacious Labs unite to create Europe’s largest cannabis investment platform.
• The Mayor of Strasbourg proposes a local cannabis consumption experiment in the city.
• Large majority of Dutch citizens (60%) are in favour of legalising the production, sale and consumption of cannabis.
• Cannabis Industry Council launches crowdfunding initiative for public awareness campaign in the UK.
• GreenBe Pharma obtains EU GMP certification at Elvas facility for cannabis flower processing.
• Cannamedical Pharma ‘well prepared’ to meet increased demand for medical cannabis in German pharmacies.

READ STOCKS REPORT »

• Colorado governor says cannabis rescheduling and banking reform are first steps on path to federal legalisation.
• U.S. cannabis industry report shows growth amid anticipation of regulatory change.
• Rhode Island cannabis company claims DEA review process is unconstitutional in new federal lawsuit.
• The most expensive adult-use legalisation campaign in U.S. history is picking up speed in Florida.
• Virginia governor vetoes two cannabis reform bills that had broad bipartisan support among lawmakers.
• South Carolina lawmakers urge House vote on medical cannabis bill, with new poll showing strong bipartisan support.

25% OFF – CODE: PROHIBITION25 »

• No international backlash over Canada’s cannabis legalisation in 2018, says Justin Trudeau.
• Tilray lowers its expectations for 2024 and could save US$80 million if taxes are cut.
• British Columbia cannabis industry urges government to implement Cannabis Act final report recommendations.
• Heritage Cannabis is the latest Canadian cannabis producer to obtain an order for creditor protection.
• Leaders in Canada’s hemp sector are disappointed that a new expert committee report ignored deregulation.
• An industrial alliance in eastern Alberta, Canada is building out a hemp supply chain.

• PharmaCielo’s Colombia-based subsidiary is set to buy Thai-based Siam Ventures Corp. in an all-stock deal.
• Green Care Pharma authorised by Conep and will invest R$20 million in clinical studies.
• The Patagonian reserve of Los Cauces is merging cannabis cultivation and ecotourism.
• Mexico’s health ministry has published rules to regulate the use of medicinal cannabis.

• Medical bodies in Australia claim medical cannabis telehealth services are under-regulated.
• Upcoming legal reforms are set to have a ‘significant impact’ and will shape the CBD market in Japan.
• Imported medicinal cannabis being sold without testing for Australian standards, industry warns.
• Health House Australia continues to make operational progress and is set to launch medical cannabis clinic in Q2 2024.

• Another sharp drop in the number of medical cannabis patients in Israel for the second month in a row.
• IM Cannabis Corp. enters a strategic distribution agreement with Vessel Brand Inc., a subsidiary of Flora Growth Corp.